Pharmacogenomics Panel

Last Modified: 5/26/2022 8:50:02 AM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:   Do not eat, drink, smoke or chew gum 30 minutes prior to saliva
Specimen Requirements:

Saliva collected in: OGD-500 Orangene-Dx collection kit 

Collection Instructions:  Saliva collected in: OGD-500 Orangene-Dx collection kit up to the "fill to" line on the device 

Transport & Storage: Temperature/Stability: 15 days Ambient
15 days Refrigerated
Rejection Criteria: Gross hemolysis; Frozen
Reference Range: Refer to Interpretive Results
Critical Ranges:  
Test Comments:  
Methodology: Microarray
Clinical Significance: Individuals with particular genotypes may find their metabolism capabilities for certain prescription drugs range from extremely poor to extremely fast, and may need to avoid or adjust to a higher or lower drug dosage in order to achieve a therapeutic effect. This test analyzes high-evidence markers for genes/loci of known pharmacogenomics value allowing clinicians to gain valuable insight into an individual's ability to metabolize drugs based on their genetic make-up. The pharmacogenomics panel reports genetic information only, currently we are not reporting medication information
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 9 to 10 days
Days Performed: Wednesday, Friday
Sites Performed: Quest - Chantilly to San Juan Capistrano
PHL Test Code: MSOT
EPIC Test Code: MISC
Send Out Test Code: 36943
Alternate Test Names: gene drug interaction; PGx; Pharmacogenetics; Polypharmacy
Included Tests:  
CPT Coding: 81225, 81226, 81227, 81230, 81231, 81232, 81247, 81283, 81291, 81306, 81328, 81335, 81350, 81355, 81381 (x4), 81400, 81404, 81479

Go back to the top of the page.